Automated External Defibrillator Market By Product 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Automated External Defibrillator Market
Automated External Defibrillator Market: By Product (Advanced Life Support Defibrillators (ALS), Automated External Defibrillators (AED), Implantable Defibrillators, & Wearable Defibrillators), By End-User (Hospitals, Prehospital) & By Region-Forecast (2016-2021)
Report Code : HCR 0159
Published: 29 March, 2016   No. of pages: 147

  • Report Description
  • Table of Contents
  • Customization Options
Continuously changing food habits and lifestyle have increased the occurrence of various cardiac disorders resulting in sudden cardiac arrest. In a sudden cardiac arrest, the heart stops beating owing to affect to its electrical system and hence the blood flow to the brain and other organs are interrupted. In this cases defibrillators are needed to provide effective results. Defibrillator can detect and identify life threating arrhythmias and let natural pacemaker cells re-establish the normal cardiac rhythm. Globally, increasing number of cardiovascular diseases across the globe, and rapid growth in aging population are the prime growth drivers of global automated external defibrillator market. In addition, emerging economies such as China, India and others will create new opportunities for global automated external defibrillator market. However, issues with the use of implantable and automated external defibrillator and safety concerns are the key restraints for global automated external defibrillator market.

This report identifies the global automated external defibrillator market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global automated external defibrillator market.

Automated External Defibrillator Market

Geographically North America dominated global automated external defibrillator market, due to technological advancements and product innovations, and rising prevalence of obesity. Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, and modernizing healthcare infrastructure in this region. Among all the end-users, Hospitals has the highest market share in global automated external defibrillator market.

This report segments global automated external defibrillator market on the basis of product, end-user, and regional market as follows:

  • Automated External Defibrillator Market, By Product: Advanced Life Support Defibrillators (ALS), Automated External Defibrillators (AED), Implantable Defibrillators, and Wearable Defibrillators
  • The report has focused study on automated external defibrillator market by basis of end-user such as: Hospitals, Prehospital, Public Access Market, Alternate Care Market, Emergency Medical Services, and Home
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the automated external defibrillator market. Some of the major companies’ profiles in detail are as follows:
  • Medtronic, Inc.
  • ST. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Biotronik Se & Co.KG
  • Sorin Group
1. Automated External Defibrillator – Market Overview
2. Executive Summary
3. Automated External Defibrillator Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Automated External Defibrillator – Market Forces
   4.1. Drivers
      4.1.1. Increasing number of cardiovascular diseases across the globe
      4.1.2. Rapid growth in aging population
   4.2. Restraints
      4.2.1. Issues with the use of implantable and automated external defibrillator
      4.2.2. Lack of awareness
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Technological advancements by development of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Automated External Defibrillator Market, By Product
   5.1. Advanced Life Support Defibrillators (ALS)
   5.2. Automated External Defibrillators (AED)
   5.3. Implantable Defibrillators
   5.4. Wearable Defibrillators
6. Automated External Defibrillator Market, By End-User
   6.1. Hospitals
   6.2. Prehospital
   6.3. Public Access Market
   6.4. Alternate Care Market
   6.5. Emergency Medical Services
   6.6. Home
7. Automated External Defibrillator Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Automated External Defibrillator – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles
   9.1. Medtronic, Inc.
      9.1.1. Introduction
      9.1.2. Financials
      9.1.3. Key Insights
      9.1.4. Key Strategy
      9.1.5. Product Portfolio
      9.1.6. SWOT Analysis
   9.2. ST. Jude Medical, Inc.
      9.2.1. Introduction
      9.2.2. Financials
      9.2.3. Key Insights
      9.2.4. Key Strategy
      9.2.5. Product Portfolio
      9.2.6. SWOT Analysis
   9.3. Boston Scientific Corporation
      9.3.1. Introduction
      9.3.2. Financials
      9.3.3. Key Insights
      9.3.4. Key Strategy
      9.3.5. Product Portfolio
      9.3.6. SWOT Analysis
   9.4. Biotronik Se & Co.KG
      9.4.1. Introduction
      9.4.2. Financials
      9.4.3. Key Insights
      9.4.4. Key Strategy
      9.4.5. Product Portfolio
      9.4.6. SWOT Analysis
   9.5. Sorin Group
      9.5.1. Introduction
      9.5.2. Financials
      9.5.3. Key Insights
      9.5.4. Key Strategy
      9.5.5. Product Portfolio
      9.5.6. SWOT Analysis
   9.6. Philips Healthcare (A Division of Koninklijke Philips N.V.)
      9.6.1. Introduction
      9.6.2. Financials
      9.6.3. Key Insights
      9.6.4. Key Strategy
      9.6.5. Product Portfolio
      9.6.6. SWOT Analysis
   9.7. Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
      9.7.1. Introduction
      9.7.2. Financials
      9.7.3. Key Insights
      9.7.4. Key Strategy
      9.7.5. Product Portfolio
      9.7.6. SWOT Analysis
   9.8. Cardiac Science Corporation (A Subsidiary of Opto Circuits India Limited)
      9.8.1. Introduction
      9.8.2. Financials
      9.8.3. Key Insights
      9.8.4. Key Strategy
      9.8.5. Product Portfolio
      9.8.6. SWOT Analysis
   9.9. Physio-Control, Inc.
      9.9.1. Introduction
      9.9.2. Financials
      9.9.3. Key Insights
      9.9.4. Key Strategy
      9.9.5. Product Portfolio
      9.9.6. SWOT Analysis
   9.10. Nihon Kohden Corporation
      9.10.1. Introduction
      9.10.2. Financials
      9.10.3. Key Insights
      9.10.4. Key Strategy
      9.10.5. Product Portfolio
      9.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports